Skip to main content

Table 2 Incidence of intraoperative adverse events

From: Study on the effectiveness and safety of ciprofol in anesthesia in gynecological day surgery: a randomized double-blind controlled study

 

Ciprofol group

Propofol group

P-value

total adverse events, n(%)

44(56.3)

93(92.2)

0.000

Bradycardia,n(%)

7(10.9)

6(9.4)

0.770

Tachycardia, n(%)

1(1.6)

0(0.0)

1.000

Hypotension, n(%)

25(39.1)

36(56.3)

0.052

Hypertension, n(%)

4(6.3)

2(3.1)

0.437

Injection pain, n(%)

1(1.6)

49(76.6)

0.000

body movements,n(%)

6(9.4)

0(0.0)

0.037